DNA-PK; DNA-PKCS (U35835) | 4.4 | | ↑ 2 (6)* |
| 11.5 | | |
| (M=7.95) | | |
DNA topoisomerase II alpha (170kDa) (J04088) | 2.6 | | ↑ 2 (6) |
| 23 | | |
| (M=12.8) | | |
rho GDP dissociation inhibitor 2; LY-GDI; ARHGDIB; GDID4 (L20688) | 3.0 | | ↑ 2 (6) |
| 24.0 | | |
| (M=13.5) | | |
Laminin beta 1 (M61916) | 4.4 | | ↑ 2 (6) |
| 5.5 | | |
| (M=4.95) | | |
Catenin (cadherin associated protein) beta 1 (88 kDa) (X87838) | 2.2 | | ↑ 2 (6) |
| 27.6 | | |
| (M=14.9) | | |
Cyclin dependent kinase 6 X66365) | 6.8 | | ↑ 2 (6) |
| 12.1 | | |
| (M=9.45) | | |
CDKN1A; melanoma differentiation associated protein 6; CIP1; WAF1 (U09579) | 29.5 | | ↑ 2 (6) |
| 42.5 | | |
| (M=36.0) | | |
v-erb-b2 avian erythroblastic leukaemia viral oncogene homolog 3 (M29366) | 13.5 | | ↑ 2 (6) |
| 4.0 | | |
| (M=8.75) | | |
BARD1 (U76638) | 2.6 | 5.4 | ↑ 2 (6)/↓ 2 (6) |
| 40.0 | 7.4 | |
| (M=21.3) | (M=6.4) | |
Hepatoma derived growth factor (high mobility group protein 1- like) (D16431) | 2.8 | | ↑ 2 (6)/↓ 1 (6) |
| 7.8 | 7.5 | |
| (M=5.3) | | |
Inhibitor of growth 1 family member 1 (AF001954) | | 9.45 | ↑ 1 (6)/↓ 2 (6) |
| 29.7 | 5.6 | |
| | (M=7.53) | |
Integrin alpha 6; VLA6, CD49F antigen (X53586) | | 2.9 | ↑ 1 (6)/↓ 2 (6) |
| 2.25 | 51.0 | |
| | (M=26.95) | |
Urokinase-type plasminogen activator receptor GPI-anchored form precursor (U-PAR); monocyte activation MO3; CD87 antigen (U08839) | | 24.7 | ↓ 2 (6) |
| | 2.6 | |
| | (M=13.65) | |
Type II cytoskeletal 8 keratin (KRT8); cytokeratin 8 (K8; CK8) (M34225) | | 2.4 | ↓ 2 (6) |
| | 3.3 | |
| | (M=2.85) | |